Discover
CGTX
Cognition Therapeutics, Inc.
1.00
1 x 1.00
1 x 1.01
bid
ask
+
0.05
5.42%
100 @ 08:03 AM
0.99 -0.01 (1.49%)
| Ytd | -25.93% | |
| 1y | 42.86% |
0.94
day range
1.02
0.55
52 week range
3.83
| Open | 0.94 | Prev Close | 0.95 | Low | 0.94 | High | 1.02 | Mkt Cap | 73.58M |
| Vol | 411.02K | Avg Vol | 1.49M | EPS | -0.24 | P/E | -4.17 | Forward P/E | -0.80 |
| Beta | 1.75 | Short Ratio | 1.07 | Inst. Own | 24.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.18 | 200-d Avg | 1.31 | 1yr Est | 6.50 |
| Income Statement | |||
| Operating Expenses | 8.82M | ||
| Research and Development Expense | 6.12M | ||
| Selling, General and Administrative Expense | 2.70M | ||
| Operating Income | -8.82M | ||
| Interest Expense | 5.00K | ||
| Net Income | -4.57M | ||
| Net Income Common Stock | -4.57M | ||
| Net Income Common Stock (USD) | -4.57M | ||
| Consolidated Income | -4.57M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -4.57M | ||
| Earning Before Interest & Taxes (USD) | -4.57M | ||
| Weighted Average Shares | 89.19M | ||
| Weighted Average Shares Diluted | 89.19M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.23M | ||
| Cash and Equivalents (USD) | 31.23M | ||
| Current Assets | 35.81M | ||
| Property, Plant & Equipment Net | 326.00K | ||
| Total Assets | 36.14M | ||
| Debt Current | 95.00K | ||
| Total Debt | 271.00K | ||
| Current Liabilities | 6.05M | ||
| Debt Non-Current | 176.00K | ||
| Total Liabilities | 6.23M | ||
| Accumulated Retained Earnings (Deficit) | -203.22M | ||
| Shareholders Equity | 29.91M | ||
| Shareholders Equity (USD) | 29.91M | ||
| Assets Non-Current | 326.00K | ||
| Total Debt (USD) | 271.00K | ||
| Deferred Revenue | 220.00K | ||
| Liabilities Non-Current | 176.00K | ||
| Trade and Non-Trade Payables | 3.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 68.00K | ||
| Net Cash Flow from Financing | -233.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.77M | ||
| Issuance (Purchase) of Equity Shares | 44.00K | ||
| Issuance (Repayment) of Debt Securities | -113.00K | ||
| Net Cash Flow from Operations | -5.54M | ||
| Share Based Compensation | 330.00K | ||